This Article Full Text Full Text (PDF) An erratum has been published An erratum has been published Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ivory, C. P. A. Articles by Chadee, K. Search for Related Content PubMed PubMed Citation Articles by Ivory, C. P. A. Articles by Chadee, K.

CpG-Oligodeoxynucleotide Is a Potent Adjuvant with an Entamoeba histolytica Gal-Inhibitable Lectin Vaccine against Amoebic Liver Abscess in Gerbils

Faculty of Medicine, Department of Microbiology and Infectious Diseases, University of Calgary Health Sciences Centre, 3330 Hospital Dr. NW, Calgary, Alberta T2N 4N1, Canada

Received 16 August 2005/ Returned for modification 20 September 2005/ Accepted 30 September 2005

The protozoan parasite Entamoeba histolytica causes invasive amoebiasis characterized by amoebic dysentery and liver abscesses (ALA). The E. histolytica galactose/N-acetyl-D-galactosamine-inhibitable lectin (Gal-lectin), an immunogenic surface molecule involved in colonization and invasion, is a promising vaccine candidate against amoebiasis. Gal-lectin is known to induce Th1 cytokines in macrophages and spleen cells in vitro, and a Th1 response is thought to be protective against ALA. In this study, we report the use of cytosine guanine oligodeoxynucleotide (CpG-ODN) as adjuvant to augment Th1 responses against Gal-lectin in the gerbil model of ALA. Gerbils were vaccinated intramuscularly with the native Gal-lectin plus CpG-ODN or a paired non-CpG control GpC-ODN, and control gerbils received CpG-ODN alone. One week after the last boost gerbils were challenged intrahepatically with 10⁶ amoebae. Gerbils receiving CpG-ODN as adjuvant with Gal-lectin were completely protected against the development of ALA, whereas 50% of gerbils receiving GpC-ODN and Gal-lectin developed ALA and 85% of controls developed ALA. Stronger lymphoproliferation in response to the Gal-lectin and higher prechallenge titers of serum Gal-lectin-specific antibodies, capable of blocking amoebic adherence, were observed when CpG-ODN was used as adjuvant. Gerbils vaccinated with CpG-ODN and Gal-lectin also had significantly higher levels of gamma interferon, interleukin-12 (IL-12), and IL-2 mRNA than controls. These data indicate that CpG-ODN can enhance the Th1 responses, which improve the protective effects of Gal-lectin. This is the first report of the use of CpG as a potent Th1 adjuvant with Gal-lectin to increase protection against ALA formation.

Editor: W. A. Petri, Jr.

This article has been cited by other articles:

• Ivory, C. P. A., Prystajecky, M., Jobin, C., Chadee, K. (2008). Toll-Like Receptor 9-Dependent Macrophage Activation by Entamoeba histolytica DNA. Infect. Immun. 76: 289-297 [Abstract] [Full Text]  
• Ivory, C. P. A., Chadee, K. (2007). Intranasal Immunization with Gal-Inhibitable Lectin plus an Adjuvant of CpG Oligodeoxynucleotides Protects against Entamoeba histolytica Challenge. Infect. Immun. 75: 4917-4922 [Abstract] [Full Text]  
• Abd Alla, M. D., White, G. L., Rogers, T. B., Cary, M. E., Carey, D. W., Ravdin, J. I. (2007). Adherence-Inhibitory Intestinal Immunoglobulin A Antibody Response in Baboons Elicited by Use of a Synthetic Intranasal Lectin-Based Amebiasis Subunit Vaccine. Infect. Immun. 75: 3812-3822 [Abstract] [Full Text]  
• HAQUE, R., MONDAL, D., SHU, J., ROY, S., KABIR, M., DAVIS, A. N., DUGGAL, P., PETRI, W. A. JR (2007). CORRELATION OF INTERFERON-{gamma} PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS WITH CHILDHOOD MALNUTRITION AND SUSCEPTIBILITY TO AMEBIASIS. Am J Trop Med Hyg 76: 340-344 [Abstract] [Full Text]